volasertib
Showing 1 - 13 of 13
Leukemia, Myeloid, Acute Trial in Worldwide (Placebo, Volasertib, Cytarabine)
Completed
- Leukemia, Myeloid, Acute
- Placebo
- +2 more
-
Los Angeles, California
- +121 more
Oct 25, 2021
MDS, Leukemia, Myelomonocytic, Chronic Trial in France, Germany (Azacitidine, Volasertib)
Terminated
- Myelodysplastic Syndromes
- Leukemia, Myelomonocytic, Chronic
- Azacitidine
- Volasertib
-
Marseille, France
- +13 more
Sep 11, 2018
MDS Trial in Fukui, Yoshida-gun (Volasertib, Azacitidine)
Terminated
- Myelodysplastic Syndromes
- Volasertib
- Azacitidine
-
Fukui, Yoshida-gun, JapanUniversity of Fukui Hospital
Aug 8, 2018
Leukemia, Myeloid, Acute Trial in Japan (Volasertib)
Completed
- Leukemia, Myeloid, Acute
- Volasertib
-
Chuo-ku, Tokyo, Japan
- +5 more
Oct 23, 2017
MDS, Leukemia, Myelomonocytic, Chronic Trial in Japan (Azacitidine, Volasertib)
Completed
- Myelodysplastic Syndromes
- Leukemia, Myelomonocytic, Chronic
- Azacitidine
- Volasertib
-
Aichi, Nagoya, Japan
- +3 more
Oct 23, 2017
AML Trial in Boston (Volasertib, Cytarabine, Idarubicin)
Withdrawn
- AML
- Volasertib
- +3 more
-
Boston, Massachusetts
- +1 more
May 3, 2018
Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Germany (Volasertib, Cytarabine, Daunorubicin)
Terminated
- Acute Myeloid Leukemia (AML)
- High-risk Myelodysplastic Syndrome (MDS)
- Volasertib
- +3 more
-
Aschaffenburg, Germany
- +44 more
Feb 27, 2018
Leukemia, Myeloid, Acute, Leukemia, Monocytic, Acute, Leukemia, Myelomonocytic, Acute Trial in Calgary, Edmonton (Volasertib,
Withdrawn
- Leukemia, Myeloid, Acute
- +4 more
- Volasertib
- +2 more
-
Calgary, Alberta, Canada
- +1 more
Apr 3, 2017
Leukemia, Myeloid, Acute Trial in Gent (Volasertib)
Withdrawn
- Leukemia, Myeloid, Acute
- Volasertib
-
Gent, BelgiumBoehringer Ingelheim Investigational Site
Jan 26, 2017
Recurrent Adult Acute Lymphoblastic Leukemia, Refractory Adult Acute Lymphoblastic Leukemia Trial in Palo Alto, Baltimore
Withdrawn
- Recurrent Adult Acute Lymphoblastic Leukemia
- Refractory Adult Acute Lymphoblastic Leukemia
- Laboratory Biomarker Analysis
- +3 more
-
Palo Alto, California
- +1 more
Dec 13, 2016